Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Cements Its Position in the Expanding Cannabis Industry
Global patents for innovative formulations and drug delivery platforms Strong development pipeline for cannabinoid-based pharmaceutical and nutraceutical products Capabilities to manufacture products of a quality unmatched by other industry players Canadian biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) continues to strengthen its position in the cannabis industry through the development of its patent-protected bio-cannabis products. The company’s current initiatives are geared toward the manufacture and commercialization of its product pipeline in anticipation of cannabis legalization in Canada, the United States and other regulated international markets. Pivot’s unique approach incorporates the acquisition of disruptive drug formulation and delivery…